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Background: Reports of the clinical characteristics of children and adolescents with anxiety disorders are
typically based on community populations or from clinical samples with exclusion criterion applied.
Little is known about the clinical characteristics of children and adolescents routinely referred for
treatment for anxiety disorders. Furthermore, children and adolescents are typically treated as one
homogeneous group although they may differ in ways that are clinically meaningful.
Methods: A consecutive series of children (n¼100, aged 6–12 years) and adolescents (n¼100, aged
13–18 years), referred to a routine clinical service, were assessed for anxiety and comorbid disorders,
school refusal and parental symptoms of psychopathology.
Results: Children with a primary anxiety disorder were signiﬁcantly more likely to be diagnosed with
separation anxiety disorder than adolescents. Adolescents with a primary anxiety disorder had
signiﬁcantly higher self and clinician rated anxiety symptoms and had more frequent primary diagnoses
of social anxiety disorder, diagnoses and symptoms of mood disorders, and irregular school attendance.
Limitations: Childhood and adolescence were considered categorically as distinct, developmental
periods; in reality changes would be unlikely to occur in such a discrete manner.
Conclusions: The ﬁnding that children and adolescents with anxiety disorders have distinct clinical
characteristics has clear implications for treatment. Simply adapting treatments designed for children to
make the materials more ‘adolescent-friendly’ is unlikely to sufﬁciently meet the needs of adolescents.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
1. Introduction
Anxiety disorders typically have an early age of onset, with a mean
of 10 years or younger (Keller et al., 1992; Orvaschel et al., 1995), and
are among the most common psychiatric disorders experienced by
children and adolescents (Essau and Gabbidon, 2013). They cause
substantial impairment at school, home and socially (Essau et al.,
2000; Wittchen et al., 1999) and, without treatment, often continue
into adulthood and are associated with negative life course outcomes
(Last et al., 1997; Pine et al., 1998). Consequently, it is of great
importance to have a clear understanding of how anxiety disorders
present in children and adolescents seeking treatment, in order to
develop and reﬁne effective treatments.
Randomized controlled trials of psychological treatments (most
commonly Cognitive Behavior Therapy, CBT) for anxiety disorders
in youth have typically included children and adolescents from
a broad age range (e.g. 7–17 years, Walkup et al., 2009) and
treatment programs have often been developed with samples that
are predominantly in middle childhood (e.g. Barrett et al., 1996;
Kendall, 1994), with very little theory or practice-research focusing
on adolescents with anxiety disorders (Kendall et al., 2013). A ﬁrst
step in establishing whether and how treatments may need to be
adapted for adolescents referred for treatment for anxiety dis-
orders is determining whether their clinical characteristics differ
from their younger counterparts.
Understanding of the epidemiology of anxiety disorders in
childhood and adolescence has been informed by a number of
large community studies. The majority of studies have found that
differences in the prevalence of particular anxiety disorders
emerge as children move into adolescence, with decreased rates
of separation anxiety disorder (SAD) (Cohen et al., 1993; Compton
et al., 2000; Copeland et al., 2014; Costello, 2003) and increased
rates of panic disorder, agoraphobia and obsessive compulsive
disorder (OCD) among both sexes (Costello et al., 2003; Ford et al.,
2003), and social anxiety disorder and GAD in girls (Copeland
et al., 2014; Costello et al., 2003). There is also some evidence for
a sharp decrease in anxiety disorders generally around the age of
11 to 12 years, as rates of SAD decline, before overall rates increase
across disorders from early adolescence to young adulthood
(Copeland et al., 2014).
Most reports of the clinical characteristics of anxiety disorders
include children and adolescents from a broad age range, e.g. 5–18
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years (Last et al., 1992), 7–17 years (Kendall et al., 2010) and there
has been relatively little examination of whether differences apply
between clinical populations of children and adolescents referred
for treatment of anxiety disorders. When children and adolescents
seeking help for anxiety disorders have been compared the
pattern of results is broadly consistent with community studies,
with children having more symptoms and more frequent diag-
noses of SAD and adolescents having more social anxiety symp-
toms/diagnoses (Compton et al., 2000; Esbjørn et al., 2010; Kendall
et al., 2010). Indeed in a Danish sample of referred children and
adolescents (Esbjørn et al., 2010), the frequency of social anxiety
disorder diagnoses was over ﬁve times higher in adolescent boys,
and over 10 times higher in adolescent girls, compared to the rates
in children. Other differences in clinical characteristics between
children and adolescents with anxiety disorders include greater
comorbidity among children and higher clinician-rated severity
among adolescents (in a research population with primary diag-
noses of SAD, social anxiety disorder or generalized anxiety
disorder (GAD) (Kendall et al., 2010). These ﬁndings are important
as elevated initial severity, the presence of social anxiety disorder
and older age (7–11 years versus 12–17 years) have each been
found to be associated with relatively poor treatment outcomes
(Kendall et al., 2010).
Whether other key characteristics that distinguish children and
adolescents with anxiety disorders in community populations,
such as the frequency of comorbid mood and behavioral disorders,
are reﬂected in referred samples has not been thoroughly eval-
uated, as young people with comorbid mood disorders or other
difﬁculties, such as school refusal, are often excluded from treat-
ment studies (e.g. Kendall et al., 2010). Nevertheless, higher levels
of major depressive disorder (MDD) and lower levels of attention
deﬁcit disorder (ADD) have been found among adolescents com-
pared to children with a diagnosis of overanxious disorder1 (OAD)
(Strauss et al., 1988). There is also some suggestion that difﬁculties
in the school environment may be more common among adoles-
cents; when examining youth with SAD, Francis et al. (1987) found
that 100% of adolescents complained of physical symptoms in
school days, compared to 58–69% of children. This is consistent
with the ﬁnding that over 50% of adolescents who do not regularly
attend school have an anxiety disorder (Last et al., 1998; McShane
et al., 2001) and is important as school refusal has serious
implications for development and functioning in adolescence
and adulthood (Berman et al., 2000), and may present a challenge
in delivering effective treatment for anxiety disorders (Albano,
1995).
The current study compares the clinical characteristics of
a consecutive series of children and adolescents referred to a
routine clinical service for the treatment of anxiety disorders and
builds on previous work by including a representative sample of
children and young people systematically assessed for the full
range of anxiety disorders, and comorbid conditions. We consid-
ered a range of factors that have been found to be associated with
treatment outcome among youth with anxiety disorders, speciﬁ-
cally, disorder subtypes (Ginsburg et al., 2011; Kerns et al., 2013),
anxiety severity (Ginsburg et al., 2011; Liber et al., 2010; Southam-
Gerow et al., 2001), symptoms of other common comorbid condi-
tions (i.e. other anxiety disorders, mood and behavioral problems
(Berman et al., 2000; Hudson et al., 2013), levels of school
attendance (Last et al., 1998; Layne et al., 2003) and symptoms
of psychopathology among caregivers (Berman et al., 2000;
Cobham et al., 1998; Southam-Gerow et al., 2001). On the basis
of community and clinic-based studies we hypothesized that
adolescents with a primary anxiety disorder would be character-
ized by higher anxiety severity and more frequent social anxiety
disorder, comorbid mood disorders, and irregular school atten-
dance than children with a primary anxiety disorder. We also
hypothesized that children would have more frequent SAD, and
a greater number of comorbid anxiety disorders and behavior
disorders than adolescents. As parental emotional difﬁculties have
often been implicated in relation to treatment outcomes for
children and adolescents with anxiety disorders (Berman et al.,
2000; Cobham et al., 1998; Southam-Gerow et al., 2001), we also
explored whether symptoms of anxiety, stress and depression in
caregivers differed according to child/adolescent age group.
Finally, as differences in clinical characteristics may be moderated
by child gender (Esbjørn et al., 2010; Rao et al., 2007), we also
explored the interaction between age group and gender in relation
to the above variables.
2. Methods
2.1. Participants
All children and adolescents were referred by primary and
secondary care services to the Berkshire Healthcare NHS Founda-
tion Trust Child and Adolescent Mental Health Service (CAMHS)
Anxiety and Depression Pathway, based at the University of
Reading. This county-wide service accepts referrals for children
and adolescents (up to 18 years) for the assessment and treatment
of anxiety disorders. Referrals for those with a diagnosed comor-
bid autistic spectrum disorder (ASD) or learning disability are not
accepted by this service, as they are seen within another specialist
CAMHS team. In accordance with the removal of OCD and PTSD
from the broad anxiety disorders category in DSM-5 (American
Psychiatric Association, 2013), young people with a primary
diagnosis of OCD are often referred directly to a specialist OCD
service and young people with complex PTSD (e.g. where there
has been abuse) would typically be referred directly to another
specialist CAMHS team; therefore children and adolescents with
OCD and PTSD are likely to be under-represented.
100 children between 6 and 12 years of age and 100 adoles-
cents between 13 and 18 years of age, and their primary caregiver,
were recruited. Both groups represent 100 consecutive assess-
ments that were conducted between October 2012 and December
2013 for the children and between June 2012 and December 2013
for the adolescents. Table 1 provides demographic information for
the children and adolescents in this study. Both groups contained
a greater number of girls than boys, especially the adolescent
group, but the gender difference between the age groups fell short
of statistical signiﬁcance (χ²(1)¼3.31, p ¼ .07). For the majority of
children and adolescents, the primary caregiver taking part in the
assessment was the child or adolescent's biological parent (for two
children and one adolescent, the primary caregiver was a grand-
parent and one child had been adopted). As shown in Table 1,
there were no signiﬁcant differences in ethnicity, socio-economic
status or caregiver gender between the age groups.
2.2. Procedure
Permission to use routine clinical information for research
purposes was provided by the Clinical Audit Department of
Berkshire Healthcare NHS Foundation Trust. Assessments were
conducted at one time point and involved the child/adolescent and
their primary caregiver being seen separately to undertake a
diagnostic assessment (of the child/adolescent) and complete
standardized questionnaires. All assessments were carried out by
1 The diagnostic category of OAD (American Psychiatric Association, 1987) was
characterized by excessive worries about multiple future and past events, and was
replaced by Generalized Anxiety Disorder (GAD) in DSM-IV (American Psychiatric
Association, 1994).
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psychology graduates (assistant psychologists or trainee clinical psy-
chologists) who received thorough training and regular supervision.
2.3. Measures
2.3.1. Diagnoses
Children and adolescents' diagnoses were determined using
the ADIS-C/P (Silverman and Albano, 1996). This is a structured
interview, with good psychometric properties (Silverman et al.,
2001), designed to assess current DSM-IV anxiety disorders.
Sections on current mood, behavioral disorders and school refusal
were also administered. As is standard, if the child/adolescent met
symptom criteria for a diagnosis, on the basis of his/her report or
that of his/her parent, the assessor assigned a Clinician Severity
Rating (CSR), ranging from 0 (absent or none) to 8 (very severely
disturbing/disabling); a CSR of 4 or more based on the child/
adolescent and/or parent report indicated the child met criteria for
diagnosis. The diagnosis with the highest CSR was classed as the
primary diagnosis. Overall reliability for the assessment team was
very good; reliability for the ADIS-C/P diagnosis was .92 (child
report) and .82 (caregiver report) and for CSR scores was .94 (child
report) and .98 (caregiver report).
2.3.2. Symptom measures
The Spence Children's Anxiety Scale (SCAS-C/P) (Spence, 1998)
assesses child/adolescent and parent-reported symptoms relating
to six domains of anxiety: panic attacks/agoraphobia, separation
anxiety, physical injury fears, social phobia, generalized anxiety
and obsessive-compulsive symptoms. The SCAS includes 38 items
to assess anxiety symptoms (and 6 positive ﬁller items in the child
version), each scored on a 4-point Likert scale, ranging from 0
(never) to 3 (always). The measure has been validated for use with
children/adolescents aged from 6–18 years and both versions have
good reliability, as well as discriminant and convergent validity
(Nauta et al., 2004; Spence et al., 2003). Internal consistent for this
scale was good to excellent (SCAS-C α ¼ .82; SCAS-P α ¼ .91).
The Short Mood and Feelings Questionnaire (SMFQ-C/P) (Angold
et al., 1995) is a self-report measure to assess child/adolescent
depression. There are versions for children/adolescents and parents
to complete; both versions have 13 items and each item is scored on
a 3-point scale (‘not true’, ‘sometimes’ or ‘true’). The scale has been
validated with children/adolescents aged 6–17 years and has good
internal reliability and discriminant validity (Angold et al., 1995).
Internal consistency for the SMFQ was good to excellent (SMFQ-C α
¼ .77; SMFQ-P α ¼ .90).
The conduct problems subscale of the Strengths and Difﬁculties
Questionnaire (SDQ-P) (Goodman, 1997) was administered to
assess parent-reported behavioral disturbance. Five items are
scored on a 3-point scale (‘not true’, ‘somewhat true’ and ‘certainly
true’). The scales show acceptable internal consistencies and retest
reliability (Goodman, 2001). Although there is a version for
children/adolescents aged from 11–17 years old to rate themselves,
the parent-report version of the SDQ was used as parents are often
considered to be most reliable in reporting on children's externa-
lizing symptoms (Grills and Ollendick, 2003). Although internal
consistency was poor (SDQ-P conduct problems α ¼ .514), this is
likely to reﬂect the relatively low number of items in the subscale.
2.3.3. Caregivers' symptoms of anxiety, depression and stress
Caregivers' own symptoms of psychological functioning were
assessed using the short-version of the Depression Anxiety Stress
Scales (DASS) (Lovibond and Lovibond, 1995). This 21-item, self-
report measure has three scales relating to symptoms of anxiety,
stress and depression. Each scale consists of 7 items and items are
scored using a scale of 0 to 3, where 0 ‘did not apply to me at all’
and 3 ‘applied to me very much or most of the time’. The DASS-21
has been used with non-clinical and clinical populations and the
scales show good internal consistency and concurrent validity
(Antony et al., 1998). Internal consistency for the DASS was good to
excellent (DASS-D α ¼ .92; DASS-A α ¼ .85; DASS-S α ¼ .88).
2.4. Data analysis
Main effects of age group and gender and the interaction of age
group x gender in predicting clinical characteristics were exam-
ined using binary logistic regression for dichotomous variables,
and factorial analysis of variance for continuous variables. How-
ever, there were no signiﬁcant effects of gender or gender x age
group interactions and so simple tests of association with age
group are reported below (independent t-tests and Pearson's chi-
square tests) for ease of interpretation. For non-Normally distrib-
uted data, differences were explored using non-parametric and
parametric tests; as results did not differ, analyses using para-
metric tests will be reported. All tests were two-tailed. Because of
small cell numbers in some cases, statistical analyses were only
run for the most common disorders (SAD, GAD, social anxiety
disorder and speciﬁc phobias). Descriptive data are given for all
disorders and are presented in Tables 2 and 3.
3. Results
3.1. Primary disorder
Eighty-four percent of both the child and adolescent groups
met criteria for an anxiety disorder as the primary diagnosis on
the ADIS (see Table 2). Where this was not the case, 6% of children
and 9% of adolescents had another primary disorder (of the
children, 4% had ODD, 1% had ADHD and 1% had MDD; of the
Table 1
Demographic information for all participants.
Children (n¼100) Adolescents (n¼100) Statistic (children vs
adolescents)
Male (n¼38) Female (n¼62) All (n¼100) Male (n¼26) Female (n¼74) All (n¼100)
Age in months (mean [SD],
range)
118.05 [17.44],
73–154
114.23 [21.03],
79–154
115.68 [19.74],
73–154
180.23 [2.94],
158–212
185.18 [16.88],
156–218
183.89 [16.49],
156–218
–
Ethnicity (% White British) 74% 84% 80% 100% 88% 91% χ²(10)¼15.84, p¼ .10
Family SES (% “higher
professional”)
66% 65% 65% 65% 58% 60% χ²(2)¼2.79, p¼ .25
Caregiver gender (female:
male)
33:5 58:4 91:9 23:3 70:4 93:7 χ²(1)¼ .27, p¼ .60
Note: SES¼socio-economic status.
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Table 2
Child/adolescent primary disorder and Anxiety Disorder Severity Ratings as measured by the ADIS-C/P.
Children Adolescents Statistic
Male
(n¼38)
Female
(n¼62)
All
(n¼100)
Male
(n¼26)
Female
(n¼74)
All
(n¼100)
(children vs
adolescents)
Anxiety disorders SAD 5 (13%) 14 (23%) 19 2 (8%) 2 (3%) 4 χ²(1)¼11.33, p¼ .001
Social anxiety
disorder
6 (16%) 11 (18%) 17 8 (33%) 21 (28%) 29 χ²(1)¼4.31, p¼ .04
GAD 8 (21%) 18 (29%) 26 6 (25%) 13 (18%) 19 χ²(1)¼1.49, p¼ .22
Speciﬁc phobia 4 (11%) 8 (13%) 12 3 (12%) 15 (20%) 18 χ²(1)¼1.46, p¼ .23
PD w/o agoraphobia 0 0 0 1 (4%) 2 (3%) 3 –
PD with agoraphobia 0 0 0 3 (12%) 4 (5%) 7 –
Agoraphobia w/o PD 1 (3%) 1 (2%) 2 1 (4%) 0 1 –
PTSD 0 0 0 0 0 0 –
OCD 2 (5%) 1 (2%) 3 0 3 (4%) 3 –
ADNOS 2 (5%) 3 (5%) 5 0 0 0 –
Total anxiety disorders 28 (74%) 56 (90%) 84 24 (92%) 60 (81%) 84 –
CSR for anxiety 4 (moderate) 9 (32%) 7 (13%) 16 1 (4%) 4 (5%) 5 –
disorder 5 (moderate) 5 (18%) 22 (39%) 27 9 (38%) 20 (33%) 29 –
6 (severe) 13 (46%) 24 (43%) 37 9 (38%) 21 (35%) 30 –
7 (severe) 1 (4%) 3 (5%) 4 5 (21%) 15 (25%) 20 –
8 (very severe) 0 0 0 0 0 0 –
CSR (mean [SD]) 5.21 [.96] 5.41 [.78] 5.35 [.84] 5.75 [.85] 5.78 [.90] 5.77 [.88] t(166)¼ 3.22,
p o .01
Comorbid anxiety disorders (mean
[SD])
0.61 [.96] 1.20 [1.20] 1.00 [1.15] 0.83 [.82] 0.82 [.79] 0.82 [.79] t(166)¼1.17, p ¼ .24
Mood disorder MDD 0 1 (2%) 1 1 (4%) 7 (9%) 8 –
Dysthymic disorder 0 0 0 0 0 0 –
Other ODD 4 (11%) 0 4 0 1 (1%) 1 –
Conduct disorder 0 0 0 0 0 0 –
ADHD 1 (3%) 0 1 0 0 0 –
No disorder 5 (13%) 5 (8%) 10 1 (4%) 6 (8%) 7 χ²(1)¼ .58, p¼ .45
Note: CSR¼ Clinical Severity Rating, SAD¼separation anxiety disorder, PD¼panic disorder, GAD¼generalized anxiety disorder, PTSD¼post-traumatic stress disorder,
OCD¼obsessive-compulsive disorder, ADNOS¼anxiety disorder not otherwise speciﬁed, MDD¼major depressive disorder, ODD¼oppositional deﬁant disorder,
ADHD¼attention deﬁcit hyperactivity disorder.
Table 3
Occurrence of all DSM-IV disorders and school refusal in children/adolescents with a primary anxiety disorder, as measured by the ADIS-C/P.
Children Adolescents Statistic
Male (n¼28) Female (n¼56) All (n¼84) Male (n¼24) Female (n¼60) All (n¼84) (children vs adolescents)
Anxiety disorder SAD 9 (32%) 28 (50%) 37 (44%) 5 (21%) 10 (17%) 15 (18%) χ²(1)¼13.48, po .001
Social anxiety disorder 9 (32%) 29 (52%) 38 (45%) 14 (58%) 30 (50%) 44 (52%) χ²(1)¼0.86, p¼ .35
GAD 12 (43%) 29 (52%) 41 (49%) 12 (50%) 34 (57%) 46 (55%) χ²(1)¼0.60, p¼ .44
Speciﬁc phobia 8 (29%) 22 (39%) 30 (36%) 8 (33%) 18 (30%) 26 (31%) χ²(1)¼0.43, p¼ .51
PD w/o agoraphobia 1 (4%) 0 1 (1%) 1 (4%) 4 (7%) 5 (6%) –
PD with agoraphobia 0 0 0 3 (13%) 4 (7%) 7 (8%) –
Agoraphobia w/o PD 1 (4%) 1 (2%) 2 (2%) 1 (4%) 0 1 (1%) –
PTSD 0 0 0 0 1 (2%) 1 (1%) –
OCD 2 (7%) 3 (5%) 5 (6%) 0 7 (12%) 7 (8%) –
ADNOS 2 (7%) 3 (5%) 5 (6%) 0 0 0 –
Total anxiety disorders 44 123 167 44 109 153
Anxiety disorders (mean [SD]) 1.61 [.96] 2.20 [1.20] 2.00 [1.15] 1.83 [.82] 1.82 [.79] 1.82 [.79] t(166)¼1.17, p¼ .24
CSR for anxiety 4 (moderate) 19 (43%) 48 (39%) 67 (40%) 12 (27%) 18 (16%) 30 (20%) –
disorder 5 (moderate) 8 (18%) 41 (33%) 49 (29%) 15 (34%) 47 (43%) 62 (40%) –
6 (severe) 15 (34%) 31 (25%) 46 (28%) 12 (27%) 29 (27%) 41 (27%) –
7 (severe) 2 (5%) 3 (3%) 5 (3%) 5 (12%) 15 (14%) 20 (13%) –
8 (very severe) 0 0 0 0 0 0 –
CSR (mean [SD]) 5.00 (.99) 4.91 (.86) 4.93 (.89) 5.23 (.99) 5.38 (.92) 5.33 (.94) t(318)¼ 3.90, po .001
Mood disorder MDD 1 (4%) 0 1 (1%) 3 (13%) 5 (8%) 8 (10%) –
Dysthymic disorder 2 (7%) 3 (5%) 5 (6%) 5 (21%) 11 (18%) 16 (19%) –
Total mood disorder 3 3 6 8 16 24 χ²(1)¼13.15, po .001
Other Selective mutism 0 1 (2%) 1 (1%) 0 0 0 –
ODD 1 (4%) 4 (7%) 5 (6%) 1 (4%) 4 (7%) 5 (6%) –
Conduct disorder 0 0 0 0 0 0 –
ADHD 2 (7%) 3 (5%) 5 (6%) 1 (4%) 2 (3%) 3 (4%) –
School refusal 1 (20%) 5 (9%) 6 (7%) 5 (21%) 10 (17%) 15 (18%) χ²(1)¼4.41, p¼ .04
Note: CSR¼Clinical Severity Rating, SAD¼separation anxiety disorder, PD¼panic disorder, GAD¼generalized anxiety disorder, PTSD¼post-traumatic stress disorder,
OCD¼obsessive-compulsive disorder, ADNOS¼anxiety disorder not otherwise speciﬁed, MDD¼major depressive disorder, ODD¼oppositional deﬁant disorder,
ADHD¼attention deﬁcit hyperactivity disorder.
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adolescents, 8% had MDD and 1% had ODD) and 10% of children
and 7% of adolescents had a sub-clinical level of symptoms and so
did not meet criteria for any disorder. The following analyses are
conducted with children and adolescents with an anxiety disorder
as the primary diagnosis.
3.2. Anxiety disorders
The frequency of primary DSM-IV diagnoses for both groups
are shown in Table 2, and the overall frequency of anxiety
disorders are shown in Table 3. Children were signiﬁcantly more
likely than adolescents to be diagnosed with SAD as the primary
disorder or anywhere in the diagnostic proﬁle; the odds of being
diagnosed with SAD as the primary disorder were 5.85 times
higher for children than adolescents (95% CI 1.89, 18.04) and the
odds of being diagnosed with SAD overall were 3.62 times higher
for children than adolescents (95% CI 1.79, 7.33). Adolescents were
signiﬁcantly more likely than children to be diagnosed with social
anxiety disorder as the primary disorder, with the odds 2.08
higher for adolescents than children (95% CI 1.04, 4.17). The
frequency of social anxiety disorder overall, however, was not
signiﬁcantly higher in the adolescents than the children. The
differences between age groups for the frequency of GAD and
speciﬁc phobias were not signiﬁcant, either as the primary or
overall diagnosis. The mean number of comorbid anxiety disorders
was not signiﬁcantly different for children (mean¼1.00, SD¼1.15)
and adolescents (mean¼ .82, SD¼ .79; t(166)¼1.17, p ¼ .24), and
the same pattern was found when looking at the number of
comorbid disorders associated with each of the most common
primary anxiety disorders (SAD, GAD, social anxiety disorder and
speciﬁc phobias). Clinician-rated severity levels for both the
primary anxiety disorder and for all anxiety disorders were
signiﬁcantly higher for adolescents than children, with effect sizes
in the small to medium range (primary anxiety disorder CSR d
¼ .49; all anxiety disorder CSR d ¼ .44).
3.3. Comorbid mood disorders
Adolescents with a primary anxiety disorder were signiﬁcantly
more likely to be diagnosed with a comorbid mood disorder (MDD
or dysthymic disorder) than children, with the odds 5.20 higher
(95% CI 2.00, 13.52) for adolescents than for children (see Table 3).
3.4. School refusal
Signiﬁcantly more adolescents than children with a primary
anxiety disorder were not regularly attending school; the odds
were 2.83 higher (95% CI 1.04, 7.69) for adolescents than for
children (see Table 3).
3.5. Symptom measures
Means and standard deviations for all symptom measures can
be found in Table 4. Adolescents with a primary anxiety disorder
scored signiﬁcantly higher than children with a primary anxiety
disorder on both self-reported symptoms of anxiety and depres-
sion, with small to medium effect sizes (SCAS-C d ¼ .32; SMFQ-C d
¼ .37). Differences between groups were not signiﬁcant for
caregiver-reported child/adolescent symptoms of anxiety, depres-
sion or behavioral disturbance or for caregiver symptoms of
anxiety, stress and depression.
4. Discussion
Among a consecutive series of referrals for treatment for
anxiety disorders, the majority of children and adolescents (84%)
were appropriate, meeting diagnostic criteria for a primary anxiety
disorder. Where this was not the case, around half the children
and adolescents did not meet clinical thresholds, and the other
half had either a primary mood (particularly among adolescents)
or behavioral (particularly among children) disorder. Consistent
with the hypotheses, adolescents with a primary anxiety disorder
were signiﬁcantly more likely than children to (i) be rated by
a clinician as having more severe anxiety for both the primary
anxiety disorder and anxiety disorders overall and rate themselves
as having higher levels of anxiety symptoms, (ii) be diagnosed
with social anxiety disorder as the primary disorder, (iii) be
diagnosed with a comorbid mood disorder and rate themselves
as having higher levels of depressive symptoms, and (iv) have
irregular school attendance. In addition, more adolescents than
children were diagnosed with panic disorder and/or agoraphobia
(but due to the small numbers in children, this difference was not
tested statistically). Also consistent with the hypotheses, children
with a primary anxiety disorder were signiﬁcantly more likely to
be diagnosed with SAD than adolescents as either the primary
anxiety disorder or anywhere in the diagnostic proﬁle. Contrary to
hypotheses, there were no signiﬁcant differences in the frequency
of behavioral disorders or symptoms of conduct problems, how-
ever there were relatively low levels of comorbid behavioral
disturbance in both groups. Although there were a greater number
of girls than boys in both age groups, gender was not signiﬁcantly
associated with any of the clinical characteristics either on its own
or in an interaction with age. We also did not ﬁnd signiﬁcant
differences between the age groups on the frequency of GAD and
speciﬁc phobias (as primary disorders or overall), the frequency of
Table 4
Summary of means, standard deviations and statistics for self-report data for children/adolescents with a primary anxiety disorder.
Children Adolescents Statistic
Male (max n¼28) Female (max n¼56) All (max n¼84) Male (max n¼24) Female (max n¼60) All (max n¼84) (children vs adolescents)
Child/adolescent SCAS total 35.14 (15.20) 39.26 (17.38) 37.84 (16.68) 38.95 (15.32) 44.43 (14.92) 42.97 (15.12) t(158)¼ 2.04, p¼ .04
Report SMFQ total 6.29 (4.37) 7.19 (5.56) 6.88 (5.17) 8.39 (6.13) 9.77 (8.58) 9.38 (7.94) t(158) ¼ –2.36, p¼ .02
Caregiver Report SCAS 30.79 (15.28) 36.63 (14.01) 34.59 (14.64) 40.65 (21.80) 37.44 (18.96) 38.34 (19.71) t(160)¼ –1.37, p¼ .17
SMFQ 6.89 (5.77) 7.16 (5.91) 7.07 (5.83) 9.48 (7.88) 8.55 (6.78) 8.81 (7.07) t(161) ¼ –1.72, p¼ .09
SDQ conduct 2.39 (1.95) 2.11 (1.94) 2.20 (1.94) 1.57 (1.38) 1.98 (1.75) 1.86 (1.65) t(159)¼1.22, p¼ .23
DASS-Dep 5.26 (6.33) 7.69 (8.99) 6.85 (8.21) 7.50 (9.46) 6.75 (8.02) 6.96 (8.41) t(159)¼ –0.09, p¼ .93
DASS-Anx 4.30 (4.63) 5.92 (7.90) 5.35 (6.94) 4.00 (4.49) 6.21 (7.60) 5.56 (6.89) t(157)¼ –1.19, p¼ .85
DASS-Stress 9.93 (6.00) 13.63 (7.97) 12.37 (7.53) 11.58 (8.00) 11.90 (8.72) 11.81 (8.48) t(163)¼0.45, p¼ .66
Note: Where data was missing, this was less than 10% of the dataset. DASS¼Depression Anxiety and Stress Scales, Dep¼Depression, Anx¼Anxiety, SCAS¼Spence Child
Anxiety Scale, SDQ¼Strengths and Difﬁculties Questionnaire, SMFQ¼Short Moods and Feelings Questionnaire.
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social anxiety disorder overall, frequency of comorbid anxiety
disorders or for symptoms of psychopathology among primary
caregivers.
Consistent with the results of community studies (Cohen et al.,
1993; Compton et al., 2000; Copeland et al., 2014; Costello, 2003;
Costello et al., 2003; Ford et al., 2003), in this clinical population
we found signiﬁcantly lower rates of SAD in adolescents compared
to children, a higher frequency of panic disorder and agoraphobia
and social anxiety disorder as a primary diagnosis. However,
unlike community studies (e.g. Copeland et al., 2014; Costello,
2003), when we considered diagnoses of social anxiety disorder
anywhere in the diagnostic spectrum, we did not ﬁnd signiﬁcant
differences according to age. In other words, social anxiety
disorder is not more common among adolescents compared to
children, but it was more likely to be causing the greatest
disturbance. Whether this is due to increasing social demands
that may come with adolescence requires further exploration.
We found that adolescents' anxiety symptoms were rated as
more severe than the children, replicating ﬁndings from two other
studies of clinical populations (Kendall et al., 2010; Strauss et al.,
1988) and that adolescents experienced higher levels of comorbid
depressive disorders, also consistent with ﬁndings from a clinical
population (Strauss et al., 1988). This is of particular note in light of
Wittchen et al.'s(2003) ﬁnding that more severe anxiety disorders
were associated with an increased risk of subsequent depression.
This may reﬂect more pervasive interference with the ability to
undertake important educational, social and leisure activities and
achieve crucial milestones among adolescents. In addition, difﬁ-
culties regularly attending school are commonly associated with
anxiety (Francis et al., 1987; Last et al., 1998); we found that this
was particularly the case among adolescents. It is of interest,
however, that greater levels of symptom severity, mood disorders
and difﬁculties attending school are not mirrored by increased
symptoms of depression, anxiety and stress among caregivers of
adolescents.
4.1. Strengths
The strengths of this research are that the young people come
from a routine clinical service for young people with anxiety and
depression and unlike existing studies (e.g. Francis et al., 1987;
Kendall et al., 2010; Rao et al., 2007; Strauss et al., 1988) include
young people with the full range of anxiety disorders, comorbid
mood disorders, school refusal and previous non-response to
treatment. As such, results are likely to be broadly generalizable
to other children and adolescents within standard clinical care
settings. A further strength is that extensive assessments were
undertaken by trained and reliable assessors, using standardized
clinical interviews and well-validated self-report measures, with
the young people and their caregivers assessed separately to
increase reliability (Costello, 1989).
4.2. Limitations
Nevertheless, there are limitations to the study, in that age was
considered within two categories, determined on the basis that
childhood and adolescence can be seen as distinct, developmental
periods (Erikson, 1968); in reality changes would be unlikely to
occur in such a discrete manner, and future studies should aim to
look at still narrower age bands. In addition, children and
adolescents were from a predominantly White British ethnic
background and from relatively high socio-economic backgrounds.
The sample did not include children or adolescents identiﬁed with
ASD and young people with OCD and PTSD may also be under-
represented.
4.3. Implications for treatment
The ﬁnding that children and adolescents referred for treatment
for anxiety disorders have distinct clinical characteristics has
clear implications for treatment and suggests that adapting
treatments designed for children to make the materials more
‘adolescent-friendly’ is unlikely to sufﬁciently meet the needs of
adolescents. Indeed, all of the characteristics which distinguished
adolescents from children with a primary anxiety disorder have
been found to be associated with reduced remission following
treatment (Ginsburg et al., 2011). It is of importance, therefore,
that programs are designed and delivered that adequately
address these characteristics in the treatment of anxiety dis-
orders in adolescence.
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